1 – 6 of 6
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2000
-
Mark
Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds
(
- Contribution to journal › Article
- 1998
-
Mark
Association between autoantibody markers and subtypes of DR4 and DR4-DQ in Swedish children with insulin-dependent diabetes reveals closer association of tyrosine pyrophosphatase autoimmunity with DR4 than DQ8
(
- Contribution to journal › Article
- 1997
-
Mark
Analysis of critical residues of HLA-DQ6 molecules in insulin-dependent diabetes mellitus
(
- Contribution to journal › Article
- 1996
-
Mark
Genetic and immunological findings in patients with newly diagnosed insulin-dependent diabetes mellitus
(
- Contribution to journal › Article
- 1994
-
Mark
Analysis of antibody markers, DRB1, DRB5, DQA1 and DQB1 genes and modeling of DR2 molecules in DR2‐positive patients with insulin‐dependent diabetes mellitus
(
- Contribution to journal › Article
- 1987
-
Mark
Prolonged incubation in the two-colour immunofluorescence test increases the prevalence and titres of islet cell antibodies in Type 1 (insulin-dependent) diabetes mellitus
(
- Contribution to journal › Article